• Explore /
  • Poster
  • / A study of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft tissue sarcoma.

A study of the safety and efficacy of the combination of gemcitabine and docetaxel with ontuxizumab (MORAb-004) in metastatic soft tissue sarcoma.

Abstract Poster

Authors

null

Sant P. Chawla

Sarcoma Oncology Center, Santa Monica, CA

Sant P. Chawla , Patrick Schoffski , Jean-Yves Blay , Robin Lewis Jones , Hans Gelderblom , Steven Attia , Bartosz Chmielowski , Brian Andrew Van Tine , Jonathan C. Trent II, Shreyaskumar Patel , Andrew J. Wagner , James Kert Viele , Rashmi Chugh , Axel Le Cesne , Gabriel Tinoco , Kamalesh Kumar Sankhala , Julianne Falcone , Charles Schweizer , Susan Weil , Robert G. Maki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Clinical Trial Registration Number

NCT01574716

Citation

J Clin Oncol 33, 2015 (suppl; abstr TPS10577)

DOI

10.1200/jco.2015.33.15_suppl.tps10577

Abstract #

TPS10577

Poster Bd #

220a

Abstract Disclosures

Similar Posters

First Author: Andrew L. Coveler

First Author: Miao Wang

First Author: Jia Fan

Poster

2024 ASCO Gastrointestinal Cancers Symposium

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

A phase I/II study of antroquinonol in combination with nab-paclitaxel and gemcitabine for patients with metastatic pancreatic cancer.

First Author: Yan-Shen Shan